Virus-like particle vaccine activates conventional B2 cells and promotes B cell differentiation to IgG2a producing plasma cells
- 18 April 2009
- journal article
- Published by Elsevier in Molecular Immunology
- Vol. 46 (10) , 1988-2001
- https://doi.org/10.1016/j.molimm.2009.03.008
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Mesothelin is a malignant factor and therapeutic vaccine target for pancreatic cancerMolecular Cancer Therapeutics, 2008
- Cytokines and chemokines shaping the B-cell compartmentCytokine & Growth Factor Reviews, 2007
- New perspectives in B-1 B cell development and functionTrends in Immunology, 2006
- SHIV virus-like particles bind and activate human dendritic cellsVaccine, 2004
- Papillomavirus-Like Particles Stimulate Murine Bone Marrow-Derived Dendritic Cells To Produce Alpha Interferon and Th1 Immune Responses via MyD88Journal of Virology, 2004
- T-cell–B-cell cooperationNature Reviews Immunology, 2004
- Increased Efficacy of the Immunoglobulin G2a Subclass in Antibody-Mediated Protection against Lactate Dehydrogenase-Elevating Virus-Induced Polioencephalomyelitis Revealed with Switch MutantsJournal of Virology, 2002
- IgG Fc ReceptorsAnnual Review of Immunology, 2001
- Production and Characterization of Simian-Human Immunodeficiency Virus-Like ParticlesAIDS Research and Human Retroviruses, 2000
- NEUTRALIZING ANTIVIRAL B CELL RESPONSESAnnual Review of Immunology, 1997